Mark Soto

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms”.

Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1763

N/A

0DataRank · unranked

2 citations

Rachel Okabe, Alexandra Schurer, Meng Tong, Mark Soto, Daniel Choi +12 more

Exploiting an Epigenetic Resistance Mechanism to PI3 Kinase Inhibition in Leukemic Stem Cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.11.663968

N/A

0DataRank · unranked

0 citations

Imit Kaur, Simone Sidoli, Shayda Hemmati, Ellen Angeles, Taneisha Sinclair +15 more